Relationship between B-type natriuretic peptide levels and ventilatory response during cardiopulmonary exercise test in patients with chronic heart failure

Minerva Cardioangiologica

Volumn 53, Issue 4, 2005, Pages 313-320

  Scardovi, A B ^a   Coletta, C ^a   Aspromonte, N ^a   Perna, S ^b   Infusino, T ^b   Carunchio, A ^a   D'Errigo, P ^c   Seccareccia, F ^c   De Maria, R ^d   Greggi, M ^a   Di Giacomo, T ^a   Ricci, R ^a   Ceci, V ^a  

^a SPIRITO SANTO HOSPITAL   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d CNR   (Italy)

Author keywords

Brain natriuretic peptide; Cardiopulmonary exercise test; Chronic heart failure

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BRAIN NATRIURETIC PEPTIDE; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; POTASSIUM SPARING DIURETIC AGENT;

ADULT; AGED; ARTICLE; CARBON DIOXIDE EXCRETION; CARDIOPULMONARY HEMODYNAMICS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYCLING; DISEASE SEVERITY; EXERCISE TEST; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; LUNG MINUTE VOLUME; LUNG VENTILATION; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; OXYGEN CONSUMPTION; PROGNOSIS; PROTEIN DETERMINATION; SYSTOLIC BLOOD PRESSURE;

AGED; CHRONIC DISEASE; EXERCISE TEST; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PULMONARY VENTILATION; REPRODUCIBILITY OF RESULTS;

EID: 27844566160     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Working Group on Cardiac Rehabilitation and Exercise Physiology and Working Group on Heart Failure of European Society of Cardiology. Recommendations for exercise testing in chronic heart failure patients. Eur Heart J 2001;22:37-45.
2. Task force for the diagnosis and treatment of chronic heart failure. European Society of Cardiology: W J Remme and K Swedberg. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J 2001;22:1527-60.
3. Opasich C, Pinna GD, Bobbio M, Sisti M, Demichelis B, Febo O et al. Peak exercise oxygen consumption in chronic heart failure: toward efficient use in the individual patient. J Am Coll Cardiol 1998;3:766-75.
4. Kao W, Winkel EM, Johnson MR, Piccione W, Lichtenberg R, Costanzo MR. Role of maximal oxygen consumption in establishment of heart transplant candidacy for heart failure patients with intermediate exercise tolerance. Am J Cardiol 1997;79:1124-7.
5. SOLVD Investigators. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fraction. N Engl J Med 1992;327:685-91.
6. Corra U, Mezzani A, Bosimini E, Scapellato F, Imparato A, Giannuzzi P. Ventilatory response to exercise improves risk stratification in patients with chronic heart failure and intermediate functional capacity. Am Heart J 2002;143:418-26.
7. Ponikowski P, Francis DP, Piepoli MF, Davies LC, Chua TP, Davos CH et al. Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance. Marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis. Circulation 2001;103:967-72.
8. Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998;339:321-8.
9. Cabanes L, Richaud-Thiriez B, Fulla Y, Heloire F, Vuillemard C, Weber S et al. Brain natriuretic peptide blood levels in the differential diagnosis of dyspnea. Chest 2001;120:2047-50.
10. Dao Q, Krishnaswamy P, Kazanegra R, Harrison A, Amirnovin R, Lenert L et al. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol 2001;37:379-85.
11. Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Due P et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-7.
12. Isnard R, Pousset F, Chafirovskaia O, Carayon A, Hulot JS, Thomas D et al. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure. Am Heart J 2003;146:729-35.
13. de Groote P, Dagorn JI, Soudan B, Lamblin N, McFadden E, Bauters C. B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure. J Am Coll Cardiol 2004;43:1584-9.
14. Wasserman K, Hansen JE, Sue DY, Whipp BJ. Principles of Exercise Testing and Interpretation. Philadelphia: Lea and Febiger, 1986.p.73-5.
15. Cohen-Solal A, Zannad F, Kayanakis JG, Gueret P, Aupetit JF, Kolsky H. Multicentre study of the determination of peak oxygen uptake and ventilatory threshold during bicycle in chronic heart failure. Eur Heart J 1991;12:1055-63.
16. Maisel AS, Koon J, Krishnaswamy P, Kazenegra R, Clopton P, Gardetto N et al. Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J 2001;141:367-74.
17. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
18. Chua TP, Clark AL, Amadi AA, Coats AJ. The relationship between chemosensitivity and ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 1996;27:650-7.
19. Piepoli M, Clark AL, Volterrani M, Adamopoulos S, Sleight P, Coats AJ. Contribution of muscle afferents to the hemodynamic, autonomic and ventilatory responses to exercise in patients with chronic heart failure. Circulation 1996;93:940-52.
20. Kleber FX, Vietzke G, Wernecke KD, Bauer U, Opitz C, Wensel R et al. Impairment of ventilatory efficiency in heart failure. Prognostic impact. Circulation 2000;101:2803-9.
21. Sullivan MJ, Higginbotham MB, Cobb FR. Increased exercise ventilation in patients with chronic heart failure: intact ventilatory control despite haemodynamic and pulmonary abnormalities. Circulation 1988;77:552-9.
22. Metra M, Dei Cas L, Panina G, Visioli O. Exercise hyperventilation chronic congestive heart failure and its relation to functional capacity and hemodynamics. Am J Cardiol 1992;70:622-8.
23. Weber KT, Kinasewitz GT, Janicki JS, Fishman AP. Oxygen utilization and ventilation during exercise in patients with chronic heart failure. Circulation 1982;65:1213-23.
24. Clark AL, Poole-Wilson PA, Coats AJ. Exercise limitation in chronic heart failure: central role of the periphery. J Am Coll Cardiol 1996;28:1092-102.
25. Reindl I, Wernecke KD, Opitz C, Wensel R, Konig D, Dengler T et al. Impaired ventilatory efficiency in chronic heart failure: possible role of pulmonary vasoconstriction. Am Heart J 1998;136:778-85.
26. Chua TP, Ponikowski P, Harrington D, Anker SD, Webb-Peploe K, Clark AL et al. Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 1997;29:1585-90.
27. Arzt M, Harth M, Luchner A, Muders F, Holmer SR, Blumberg FC et al. Enhanced ventilatory response to exercise in patients with chronic heart failure and central sleep apnea. Circulation 2003;107:1998-2003.
28. Arena R, Myers J, Aslam SS, Varughese EB, Peberdy MA. Peak VO2 and VE/VCO2 slope in patients with heart failure: a prognostic comparison. Am Heart J 2004;147:354-60.
29. Arena R, Humphrey R. Comparison of ventilatory expired gas parameters used to predict hospitalization in patients with heart failure. Am Heart J 2002;143:427-32.
30. Mancia G, Seravalle G, Giannattasio C, Bossi M, Preti L, Cattaneo BM et al. Reflex cardiovascular control in congestive heart failure. Am J Cardiol. 1992;69:17G-23G.
31. Narkiewicz K, Pesek CA, van de Borne PJ, Kato M, Somers VK. Enhanced sympathetic and ventilatory responses to central chemoreflex activation in heart failure. Circulation 1999;100:262-7.
32. Ponikowski P, Chua TP, Piepoli M, Ondusova D, Webb-Peploe K, Harrington D et al. Augmented peripheral chemosensitivity as a potential input to baroreflex impairment and autonomic imbalance in chronic heart failure. Circulation 1997;96:2586-94.
33. Cheng V, Kazanagra R, Garcia A, Lenert L, Krishnaswamy P, Gardetto N et al. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol 2001;37:386-91.
34. Kruger S, Graf J, Kunz D, Stickel T, Hanrath P, Janssens U. Brain natriuretic peptide levels predict functional capacity in patients with chronic heart failure. J Am Coll Cardiol 2002;40:718-22.
35. Scardovi AB, Aspromonte N, Coletta C, et al. Correlation between BNP and cardiopulmonary exercise test parameters in risk stratification of patients with chronic heart failure [abstract]. Eur J Heart Fail 2003;2 Suppl 1:P23.
36. Scardovi AB, Coletta C, Aspromonte N, et al. Utility of BNP in detecting diastolic dysfunction in chronic heart failure patients [abstract]. Eur J Heart Fail 2003;2 Suppl 1:P107.
37. Troughton RW, Prior DL, Pereira JJ, Martin M, Fogarty A, Morehead A et al. Plasma B-type natriuretic peptide levels in systolic heart failure. J Am Coll Cardiol 2004;43:416-22.
38. Corra U, Mezzan A, Bosimini E, Giannuzzi P. Cardiopulmonary exercise testing and prognosis in chronic heart failure. A prognosticating algorithm for the individual patient. Chest 2004;126:942-50.
39. Haug C, Metzele A, Steffgen J, Kochs M, Hombach V, Grunert A. Increased brain natriuretic peptide and atrial natriuretic peptide plasma concentrations in dialysis-dependent chronic renal failure and in patients with elevated left ventricular filling pressure. Clin Invest 1994;72:430-4.
40. Ishizaka Y, Yamamoto Y, Fukunaga T, Yokota N, Kida O, Kitamura K et al. Plasma concentration of human brain natriuretic peptide in patients on haemodialysis. Am J Kidney Dis 1994;24:461-72.